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Sarcoidosis is a chronic granulomatous disease of unknown aetiology, which may involve any organ system. It most commonly
occurs in adults with childhood involvement being rare. Central nervous system involvement is seen in up to 25% and typically
involves meningeal disease resulting in multiple cranial neuropathies. Other common clinical findings include seizures, headache,
dementia, and pituitary dysfunction. Imaging plays a central role in the diagnosis with typical findings including pachymeningeal
and leptomeningeal enhancing lesions. Other imaging findings include lacunar and major territory infarcts, hypothalamic and
infundibular thickening, hydrocephalus, and cranial nerve enhancement. We present a case of an eight-year-old male patient
with progressive headache, visual disturbance, unilateral sensory hearing loss, and multiple cranial neuropathies. Imaging findings
demonstrated the classic pachymeningeal and leptomeningeal enhancement along much of the skull base, as well as enhancement
of the right and left second and eighth cranial nerves. Extensive inflammatory changes were noted in the temporal bones and
paranasal sinuses. There was also enhancement of the right and left labyrinths. Sinus biopsy confirmed sarcoidosis. We present the
first case to our knowledge of sarcoid labyrinthitis.
1. Introduction
Sarcoidosis is a chronic granulomatous disease of unknown
aetiology with the presence of noncaseating granulomas
[1] .I tm a yi n v o l v ea n yo r g a ns y s t e m ,a l t h o u g ht h el u n g s
and lymphatic system are among the more common sites.
Sarcoidosis typically affects adults, with bimodal peaks in
the third decade and sixth decade [1]. It is uncommon in
childhood. There is an increased risk in people of African
ethnicity [2], although this seems to be more prevalent in
those living in northern climates. Isolated neurosarcoidosis
is rare [3]. In postmortem series of patients with sarcoidosis,
central nervous system involvement is seen in 14–25% [4–
7]. Symptomatic cases are however reported with a much
lower frequency (3%–5%) [8, 9]. This suggests that CNS
involvement is more common than clinically apparent.
D e p e n d i n go nt h eo r g a ns y s t e m si n v o l v e d ,c l i n i c a lfi n d -
ings may vary widely. With central nervous system involve-
ment, symptoms include those of cranial neuropathy, partic-
ularly the facial nerve and the optic nerve. Other symptoms
include seizures, headache, dementia, weakness, parasthesia,
and pituitary/hypothalamic dysfunction [10].
2. Case Report
Wepresentacaseofaneight-year-oldmalewithaprogressive
history of headache, neck pain, and deteriorating vision
over a six-month period. Approximately one month prior
to presentation, he developed right facial weakness and
unilateral tongue weakness. There was no history of seizures,
fever, gastrointestinal symptoms, respiratory symptoms, or
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Figure 1: Coronal post-Gad T1WI FSE. There is diffuse pachymeningeal enhancement along the anterior skull base (red arrows).
Figure 2: Coronal T2WI FSE. There is diffuse hypointense dural
thickening (red arrows).
e x p o s u r et oh e a v ym e t a l s .H i si m m u n i z a t i o nr e c o r dw a s
current and he had no recent vaccinations. No changes in
behavior or cognition were reported. Clinical examination
revealed blindness in the right eye and impaired vision in
the left eye. On formal ophthalmologic examination, right
opticdiscpallorwaspresentwithanafferentpupillarydefect.
Bilateral oculomotor and abducens nerve palsy were present.
Lo w ermo t o rpalsyo ftherigh ta ndleftfacialnerv esasw ellas
right accessory and right hypoglossal nerve was noted. There
was hearing loss of the right ear and Weber test lateralized
to the left ear. There was, additionally, mild weakness of the
soft palate suggesting involvement of the glossopharyngeal
and vagus nerves. Right hemiparesis and motor weakness of
the left lower limb were noted. The growth parameters were
normal.
Laboratory investigations revealed a hypochromic,
microcytic anemia; marked elevation of the sedimentation
rate; cerebrospinal fluid pleocytosis; hyperglobulinemia;
Figure 3: Axial post-Gad T1WI FSE. Dural enhancement is
noted along the cavernous sinuses (yellow arrows). There is dural
enhancement extending into the right internal auditory canal, with
abnormal enhancement of the facial and vestibulocochlear nerves
(red arrows).
normal serum calcium; and alkaline phosphatase. The
tuberculin skin test was negative and microscopy and
staining of gastric washings for acid fast bacilli were negative.
At presentation to our institution, the patient had under-
gone CT and MRI of the brain; the former was not avail-
able for formal review but was reported as normal. MRI
revealed extensive smooth pachymeningeal thickening and
enhancement involving the anterior, middle, and posterior
skullbase.Thisincludedthickpachymeningealenhancement
along the lateral dural margin of the right and left cavernous
sinuses, the right and left petroclinoid ligaments, and along
the right petrous temporal bone inferiorly to the level of the
foramen magnum (Figures 1, 3,a n d4). These areas of dural
enhancementandthickeningwereisointenseonnoncontrast
T1 FSE and hypointense on T2 FSE (Figure 2). There was
also dural enhancement of the walls of the right and left
internal auditory canals (more extensive on the right) as
w e l la st h ec i s t e r n a la n di n t r a c a n a l i c u l a rs e g m e n t so ft h e
seventh and eighth cranial nerves (Figures 3 and 4). There
was no apparent involvement of the petrous, tympanic, orCase Reports in Radiology 3
Figure 4: Axial post-Gad T1WI FSE. Thick dural enhancement is noted in the posterior fossa (blue arrows). There is enhancement in the left
internal auditory canal (orange arrow). There is left mastoid sinus opacification with enhancement (purple arrows). There is enhancement of
the entire right labyrinth (red arrows).
Figure 5: Sagittal post-Gad T1WI FSE. Enhancement of the right optic nerve (yellow arrows).
(a) (b)
Figure 6: (a) Precontrast T1 FSE. Opacified left mastoid sinus. (b) Postcontrast T1 FSE. There is extensive mural enhancement postcontrast.
descending segments of the facial nerves. Mild enhancement
of the leptomeningeal surfaces of the intracranial portion of
the right optic nerve, the optic chiasm, and the bilateral optic
tracts was noted (Figure 5).
Mild leptomeningeal enhancement was also noted along
the basal surfaces of the brain.
Interestingly, there was enhancement of the cochlea,
semicircularcanals,andvestibuleontheleft(Figure 4).There
was also fluid opacification of the left mastoid sinus air
cells and tympanic cavity with extensive mural enhancement
(Figures 4 and 6). Similar but less extensive changes were
also noted in the right mastoid sinus and tympanic cavity.4 Case Reports in Radiology
Figure7:AxialCT:mucosalthickeningoftheleftmaxillaryantrum
is noted with mural bony thickening (yellow arrow). There are
erosive changes involving the lateral pterygoid plates (red arrows).
Subsequent CT of the temporal bones demonstrated similar
changes in the mastoid sinuses with no associated bony
destruction.
Subtle erosive changes were also noted involving the
right and left medial and lateral pterygoid plates. There
was mild generalized mucosal thickening involving the right
and left maxillary sinuses and the anterior and posterior
ethmoidal sinuses with thickening of the associated bony
walls (Figure 7).
The patient had an otolaryngology consult and a biopsy
done of the floor and medial wall of the right maxillary sinus
andwalloftherightethmoidsinus.Thefinalpathologyreport
of that biopsy revealed sarcoidosis.
3. Discussion
Imaging findings in neurosarcoidosis are quite varied
and include varying patterns of pachymeningeal and lep-
tomeningeal enhancement, dural based masses, ischaemic
intra-axial lesions (lacunar and major territory infarcts),
hypothalamic and infundibular thickening, hydrocephalus,
and cranial nerve enhancement [10]. Many of these findings
m a yb es e e ni n t r a c r a n i a l l ya n dw i t h i nt h es p i n e .Th em o s t
commonly found finding however is T2 hypointense dural
thickening and enhancement [10–12]. This is thought to be
secondary to fibrocollagenous tissue associated with sarcoid.
Whileacommonfeatureofneurosarcoidosis,suchanappear-
ance of pachymeningeal involvement, may be seen with
entities such as Wegener granulomatosis, idiopathic hyper-
trophic cranial pachymeningitis, and rheumatoid nodulosis
[10]. When sarcoidosis involves the dura more focally, it
m a yb ec o n f u s e dw i t hm e n i n g i o m a sa n dd u r a lm e t a s t a s e s .
Cranial nerve involvement is reported to be present at MRI
in less than 50% of cases [3, 10, 13]. The inflammatory
process may spread along the perivascular spaces resulting
in vasculitis. This results in varying degrees of ischaemic
changes. At MRI these range in appearances from lacunar
infarcts to larger territory infarction. The MRI findings may
not correlate with the clinical symptoms [10, 11, 14]. Spinal
cord involvement is seen in approximately one-quarter of
patients and typically appears as fusiform enlargement of
the cervical and thoracic cord with associated increased T2
signal intensity. Its appearance therefore may be confused
withmultiplesclerosisandotherdemyelinatinglesionsofthe
spinal cord as well as infectious myelitis.
While involvement of the eighth cranial nerve is well
described in the literature, both in terms of clinical and
imaging findings [15], we have not found any report of
labyrinthine involvement in sarcoidosis. In our case, there
was enhancement of the labyrinths indicating labyrinthitis
along with coexisting otomastoiditis. There are several pos-
sible mechanisms of involvement of the labyrinth including
direct spread from the inflamed temporal bone structures as
well as venous spread. Our case represents the second case
of neurosarcoidosis in a paediatric patient at the University
Hospital of the West Indies within the last decade. It also
represents, to our knowledge, the first reported case of
labyrinthine involvement by sarcoidosis diagnosed at MRI.
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